Dr. Perlmutter, Respected Neurologist, Glutathione and Antioxidant Expert Was
Featured April 3, 2009 on Oprah and Friends With Dr. Oz to Discuss New Findings
Affecting Parkinson`s Disease
SAN DIEGO--(Business Wire)--
David Perlmutter, MD, FACN, ABIHM, internationally recognized for his expertise
in the field of neurology and recently featured with Dr. Oz on Oprah and
Friends, has joined the Scientific Advisory Board of LifeVantage Corporation
(OTCBB: LFVN).The Company`s products include Protandim® - a dietary supplement
clinically shown to induce the body`s own antioxidant defenses.
Currently, Dr. Perlmutter is involved in pioneering work in the use of
glutathione in fighting diseases such as Parkinson`s disease and Alzheimer`s.
Dr. Perlmutter appeared on Oprah and Friends on April 3, 2009 with Dr. Oz to
discuss new findings affecting Parkinson`s disease (www.oprah.com/oradio).
Protandim® was proven to raise glutathione levels up to 300 percent, in a
peer-reviewed study published in November 2008 in theFree Radical Biology and
Dr. Perlmutter commented, "The health benefits of increased glutathione are
numerous, because of its antioxidant and potential anti-aging activity factors.
Protandim`s® effects on glutathione enhancement are tremendous and as a
neurologist, I am keenly interested in the impact of Protandim® on brain
disorders as well as a variety of medical conditions and diseases. Working with
LifeVantage provides me the ability to discuss the eloquence of the science
supporting this product and its profound importance in human health."
David Brown, LifeVantage President and CEO said, "We are very pleased to welcome
Dr. Perlmutter on board with the LifeVantage team. He is known worldwide as an
expert in his field, evidenced by his recent appearance with Dr. Oz on the Oprah
and Friends show - he has the ability to disseminate the Protandim® message to
potentially millions of consumers."
About Dr. Perlmutter
David Perlmutter, MD, FACN, ABIHM is a Board-Certified Neurologist and Fellow of
the American College of Nutrition who received his M.D. degree from the
University of Miami School of Medicine where he was awarded the Leonard G.
Rowntree Research Award. After completing residency training in Neurology, also
at the University of Miami, Dr. Perlmutter entered private practice in Naples,
Neurologist Dr. Perlmutter has contributed extensively to the world of medical
literature with publications appearing in such journals as The Journal of
Neurosurgery, The Southern Medical Journal, Journal of Applied Nutrition, and
Archives of Neurology. He is the author of the bestselling book, The Better
Brain Book and Raise a Smarter Child By Kindergarten and is recognized
internationally as a leader in the field of nutritional influences in
neurological disorders. He has lectured at symposia sponsored by such respected
institutions as the University of Arizona, the University of Miami, Columbia
University, and Harvard University. Neurologist Dr. Perlmutterhas been
interviewed on many nationally syndicated radio and television programs
including 20/20, Larry King Live, CNN, Fox News, Fox and Friends, The Today
Show, Oprah, Oprah and Friends, Oprah Radio with Dr. Oz, and The CBS Early Show.
He was awarded the 2002 Linus Pauling Award for his pioneering work in
innovative approaches to neurological disorders and is the recipient of the 2006
National Nutritional Foods Association Clinician of the Year Award. For more,
Protandim® is a groundbreaking, clinically proven supplement that provides a
substantial benefit to help with the challenge of healthy aging. This patented
antioxidant therapy is more powerful than conventional foods such as red wine,
oranges, blueberries or other popular antioxidant supplements. Protandim® works
by increasing the body`s natural antioxidant protection at the cellular level,
triggering cells to produce naturally occurring protective antioxidant enzymes
such as superoxide dismutase (SOD), catalase, and glutathione synthase.
A peer-reviewed human study showed that after Protandim® was taken for 30
consecutive days, the accumulation of lipid peroxidation products (a biochemical
marker of aging) was decreased by an average of 40%. The study also reported
that this important marker of aging was decreased after taking Protandim® to the
level of a typical 20 year old. Protandim® is currently the subject of over 20
scientific studies at leading universities and research institutes. For more
information, please visitwww.LifeVantage.comor contact Jan Strode (619) 890-4040
or Jean Golden (612) 385-2324.
About LifeVantage Corporation
LifeVantage Corporation is a publicly traded (OTCBB: LFVN), science based,
natural products company, dedicated to helping people reach their health and
wellness goals through science-based solutions to oxidative stress. Founded in
2003 and based in San Diego, CA, LifeVantage develops nutraceutical products,
including Protandim®, that leverage the company's expertise and that are
intended to deliver significant health benefits to consumers. For more
information, visit www.LifeVantage.com or contact Jan Strode (619) 890-4040 or
Jean Golden (612) 385-2324.
This document contains forward-looking statements made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act of 1995.The
Company uses the words "anticipate," "believe," "could," "should," "estimate,"
"expect," "intend," "may," "predict," "project," "plan," "target" and similar
terms and phrases, including references to assumptions, to identify
forward-looking statements. These forward-looking statements are based on the
Company`s current expectations and beliefs concerning future events affecting
the Company and involve known and unknown risks and uncertainties that may cause
the Company's actual results or outcomes to be materially different from those
anticipated and discussed herein.These risks and uncertainties include, among
others, the risk that government regulators and regulations could adversely
affect our business; future laws or regulations may hinder or prohibit the
production or sale of our existing product and any future products; unfavorable
publicity could materially hurt our business; and the Company`s ability to
protect our intellectual property rights and the value of our product.These and
other risk factors are discussed in greater detail in the Company`s Annual
Report on Form 10-KSB under the caption "Risk Factors", and in other documents
filed the Company from time to time with the Securities and Exchange
Commission.The Company cautions investors not to place undue reliance on the
forward-looking statements contained in this document.All forward-looking
statements are based on information currently available to the Company on the
date hereof, and the Company undertakes no obligation to revise or update these
forward-looking statements to reflect events or circumstances after the date of
this document, except as required by law.
*These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure or prevent any disease.
Note to Editors: Contact Jan Strode at 619-890-4040 or Jean Golden at
612-385-2324 for interviews, photography, and other requests.
For LifeVantage Corporation
Jan Strode, 619-890-4040
Jean Golden, 612-385-2324
Copyright Business Wire 2009